Philadelphia's Push: Breaking Barriers in Rare Disease Research

Building off our successful BioInnovation Series launch event in February, we’re continuing the momentum with our next session—this time focused on Rare Disease Innovation. Philadelphia is home to groundbreaking advancements in rare disease research and therapeutic development, but how do we ensure these innovations lead to lasting impact, growth, and better patient outcomes?

Join us, in partnership with and , as we explore the strategies, partnerships, and breakthroughs shaping the future of rare disease treatments. This event will highlight Philadelphia’s leadership in rare disease research, featuring insights from scientists, biotech leaders, and patient advocates who are driving progress in this space.You'll hear from a rare disease patient connect with industry pioneers, researchers, and advocates working to accelerate innovation and bring new therapies to market. Most importantly, engage in a thoughtful discussion on how we can foster a thriving ecosystem that keeps rare disease companies rooted in our region.

This invite-only event is free for industry professionals, providing a unique opportunity to connect with fellow life science professionals, entrepreneurs, and advocates. Vendors are required to pay to participate. Feel free to share this with others who are passionate about advancing rare disease research and strengthening Philadelphia’s biotech ecosystem.

Space is limited—secure your spot soon by grabbing a ticket via the link below. An official invitation is attached—please pass it along to others who would be interested in this important conversation.

We look forward to seeing you there!

This session is hosted at uCity Square, a mixed-use Knowledge Community consisting of laboratory, clinical, academic, office, retail, and residential space. As Philadelphia’s central hub for medical and life science innovations, particularly in cell and gene therapy, uCity Square is connected to top-tier colleges and universities, independent research institutions, world-renowned hospitals, and is a center of connectivity for residents, students, professionals, and entrepreneurs alike. uCity Square is a development of Wexford Science & Technology, LLC, in partnership with the University City Science Center as the community’s primary engagement partner and Ventas, Inc. (NYSE: VTR) as the primary investor. For more information about uCity Square, visit www.ucitysquare.com

At this event you will learn about;

🔬 Cutting-Edge Rare Disease Research – Explore the latest scientific advancements and breakthroughs in diagnostics and therapeutics.

🧪 Translating Discoveries into Treatments – Hear from researchers and industry leaders on the challenges and opportunities in bringing rare disease treatments to market.

🤝 Collaborations Driving Innovation – Learn how partnerships between academia, biotech, and advocacy groups are accelerating progress in the rare disease space.

📢 Patient Perspectives – Gain insights from a rare disease patient whose life was transformed by treatments developed in Philadelphia.

🌍 Building a Thriving Rare Disease Ecosystem – Engage in discussions on how to support and sustain rare disease research and biotech growth in the region.

This event is designed for scientists, researchers, and industry professionals dedicated to advancing rare disease innovation—don’t miss the opportunity to connect and collaborate!

NOTE TO VENDORS: BioBuzz reserves the right to restrict registration and entry for any vendors or service providers we deem necessary for this event. Refunds will be provided when tickets have been purchased. This event is designed to be a peer-focused program for biotech and pharma industry leaders and professionals.

Info: A conversation with Rare Disease Leaders

Event Venue & Nearby Stays

Quorum, 3675 Market Street, Philadelphia, United States